Yield10 Bioscience Announces Second Quarter 2024 Financial Results
14. August 2024 16:37 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the...
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
17. Juni 2024 08:32 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced...
Yield10 Bioscience Announces Delisting from Nasdaq
15. Mai 2024 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a...
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
01. Mai 2024 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
01. April 2024 16:01 ET
|
Yield10 Bioscience, Inc.
-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
28. März 2024 16:01 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will...
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
29. Februar 2024 08:31 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported that its proprietary...
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
14. Februar 2024 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass. and LONGMONT, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, and VISION Bioenergy...
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
07. Februar 2024 17:40 ET
|
Yield10 Bioscience, Inc.
-Prioritizes Activities to Advance Omega-3 Camelina Program in 2024 -Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chile - Company also Provides Update on Nasdaq Status...
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
08. Januar 2024 08:31 ET
|
Yield10 Bioscience, Inc.
Yield10 Bioscience files RSR with USDA-APHIS for elite Camelina designed to produce EPA/DHA omega-3 oils